Does the additional use of heparin-coated extracorporeal circuits (ECC) optimize the effect of modified ultrafiltration (MUF) in pediatric perfusion?

Thoracic and Cardiovascular Surgeon

Volumn 54, Issue 3, 2006, Pages 168-172

  Harig, Frank ^a   Meier, C ^a   Hakami, L ^a   Strasser, R ^a   Bretzger, J ^a   Munch F ^a   Vestweber Wilmes, E ^a   Singer, H ^a   Weyand, M ^a   Cesnjevar, R ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Heparin coating; Modified ultrafiltration; Pediatric cardiac surgery

Indexed keywords

CD14 ANTIGEN; CD45 ANTIGEN; FIBRINOGEN RECEPTOR; HEPARIN; MEMBRANE ANTIGEN; PADGEM PROTEIN;

ARTICLE; BIOCOMPATIBILITY; BLOOD ANALYSIS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; EXTRACORPOREAL CIRCULATION; FLOW CYTOMETRY; HUMAN; INFANT; INTENSIVE CARE UNIT; MODIFIED ULTRAFILTRATION; MONOCYTE; PEDIATRIC SURGERY; PREOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; THORAX DRAINAGE; THROMBOCYTE;

ANTIGENS, SURFACE; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CHILD, PRESCHOOL; COATED MATERIALS, BIOCOMPATIBLE; EXTRACORPOREAL CIRCULATION; FIBRINOLYTIC AGENTS; HEART DEFECTS, CONGENITAL; HEMOFILTRATION; HEPARIN; HUMANS; INFANT; PERFUSION; PLATELET ACTIVATION; PROSPECTIVE STUDIES; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 33646449632     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-872863     Document Type: Article

References (20)

1. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845-857
2. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55: 552-559
3. Casey LC. Role of cytokines in the pathogenesis of cardiopulmonary- induced multisystem organ failure. Ann Thorac Surg 1993; 56: 92-96
4. Taylor KM. SIRS - The systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 1996; 61: 1607-1608
5. Naik SK, Knight A, Elliott MJ. A successful modification of ultrafiltration for cardiopulmonary bypass in children. Perfusion 1991; 6: 41-50
6. Elliott MJ. Ultrafiltration and modified ultrafiltration in pediatric open heart operations. Ann Thorac Surg 1993; 56: 1518-1522
7. Davies MJ, Nguyen K, Gaynor JW, Elliott MJ. Modified ultrafiltration improves left ventricular systolic function in infants after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1998; 115: 361-370
8. Dagget CW, Lodge AJ, Scarborough JE, Chai PJ, Jaggers J, Ungerleider RM. Modified ultrafiltration versus conventional ultrafiltration: a randomized prospective study in neonatal piglets. J Thorac Cardiovasc Surg 1998; 115: 336-342
9. Ungerleider RM. Effects of cardiopulmonary bypass and use of modified ultrafiltration. Ann Thorac Surg 1998; 65: 35-39
10. Boyle EM Jr, Pohlman TH, Johnson MC, Verrier ED. The systemic inflammatory response. Ann Thorac Surg 1997; 64: 31-37
11. Muench F, Vestweber-Wilmes E, Bretzger J, Hakami L, Weyand M, Cesnjevar R. "MUF deLuxe"- Erlanger Verfahren der modifizierten Ultrafiltration. Kardiotechnik 2003; 4: 138-141
12. Feyrer R, Blum U, Disput A, Katalinic EA, von der Emde J. Heparin coating of extracorporeal circuits reduces neuropsychologic dysfunction after Cardiac Surgery. Thorac Cardiov Surg 1997; 45 (Suppl I): 65
13. Harig F, Hohenstein B, von der Emde J et al. Immunomonitoring during and after CPB for analysis of cytokine secretion patterns and developing of a preventive strategy of SIRS after cardiac surgery. Thorac Cardiov Surg 1997; 45 (Suppl I): 65, 138
14. Cremer J, Haverich A, Borst HG et al. Systemic inflammatory response after cardiac operations. Ann Thorac Surg 1996; 61: 1714-1720
15. Gruenenfelder J, Zuend G, Turina M et al. Modified ultrafiltration lowers adhesion molecule and cytokine levels after cardiopulmonary bypass. Eur J Cardiothorac Surg 2000; 17: 77-83
16. Harig F, Hohenstein B, von der Emde J, Weyand M. Modulating IL-6 and IL-10 levels by pharmacologic strategies and the impact of different extracorporeal circulation parameters during cardiac surgery. Shock 2001; 16(Suppl 1): 33-38
17. Harig F, Feyrer R, Mahmoud FO, Blum U, von der Emde J. Reducing the post-pump syndrome by using heparin-coated circuits, steroids, or aprotinin. Thorac Cardiovasc Surg 1999; 47: 111-118
18. Svenmarker S, Haggmark S, Jansson E, Lindholm R, Appelblad M, Sandstrom E, Aberg T. Use of heparin-bonded circuits in cardiopulmonary bypass improves clinical outcome. Scand Cardiovasc J 2002; 36: 241-246
19. Flom-Halvorsen HI, Ovrum E, Brosstad F, Tangen G, Ringdal M, Oystese R. Effects of two differently heparin-coated extracorporeal circuits on markers for brain and myocardial dysfunction. Perfusion 2002; 17: 339-345
20. Sbrana S, Bevilacqua S, Buffa M, Spiller D, Parri MS, Gianetti J, de Filippis R, Clericio A. Post-reperfusion changes of monocyte function in coronary blood after extracorporeal circulation. Cytometry Part B (Clinical Cytometry) 2005; 65B: 14-21